News for PeptiDream Inc. (PPTDF)

PeptiDream's PDPS platform offers a promising investment opportunity due to the new therapeutic class of macrocyclic peptide. Read my analysis of PPTDF stock.

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan GlobeNewswire October 01, 2024 Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&TBuilds on long-standing relationship between the two companiesIn Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS,...

NCC and PeptiDream Announce the First Dosing of ¶ ´Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company today announced a new multi-target collaboration and license agreement with U.S.-based Genentech, a member of the Roche...

PeptiDream Inc. announced a new multi-target collaboration and license agreement with U.S.-based Genentech, a member of the Roche Group, focused on the discovery and development of novel macrocyclic...

/PRNewswire/ -- PeptiGrowth Inc (PeptiGrowth), a Japanese biotechnology company focusing on the development of synthetic peptide based growth factors and...

North America held the largest peptide therapeutics market share, which was valued at $10,869.48 million in 2020 and is estimated to grow at a CAGR of 9.4%...

/PRNewswire/ -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and...

Japan isn’t known for its startup culture. Tomotaka Goji, a bureaucrat-turned-technology guru, is working hard to change that. The 51-year-old runs a low-profile venture fund in Tokyo that has quietly built a track record that would make Silicon Valley’s finest envious. He’s done it by blending his experiences at Stanford…

Note: This document has been translated from the Japanese original version for reference purposes only. In the event of any discrepancy between this translated document and the... | March 6, 2023

News Release January 25, 2023 PeptiDream Inc. https://www.peptidream.com ... | January 25, 2023